En esta página
VERA Clase A Vera Therapeutics, Inc. - Class A Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$30,42
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$23,05mínimo 52 semanas
$56,05máximo 52 semanas
P/E
-10.9
BPA
$-4.66
tus insignias
Rango 52S
$23–$56
Calificación del Analista
BUY
Precio Objetivo
$78
P/E
-10.9
ROE
-55.9%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
VERA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$30.42
P/E
-10.9
BPA
$-4.66
ROE
-55.9%
Rango 52S
$23–$56
VERA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-4.662021-12-31 → 2025-12-31
Flujo de caja libre$-242M2022-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | VERA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -10.9promedio 5A ≈-10.0 | ≈-10.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | VERA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -43.1%promedio 5A ≈-54.4% | ≈-54.4% | -40.3% | Débil | |
| ROE | -55.9%promedio 5A ≈-63.2% | ≈-63.2% | -54.5% | Débil | |
| ROIC | -52.2%promedio 5A ≈-69.8% | ≈-69.8% | -52.2% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | VERA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 10.9promedio 5A ≈12.5 | ≈12.5 | 13.0 | Por debajo del promedio | |
| Quick Ratio (Ratio Rápido) | 13.4promedio 5A ≈12.1 | ≈12.1 | 6.6 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-14.3%
Próximo informe
Nov 03, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 3, 2026 | $-1.52 | $-1.61 | 5.5% |
| 31 de marzo de 2026 | $-1.69 | $-1.35 | -24.9% | |
| 31 de diciembre de 2025 | $-1.39 | $-1.31 | -6.3% | |
| 30 de septiembre de 2025 | $-1.26 | $-1.16 | -8.8% | |
| 30 de junio de 2025 | $-1.20 | $-0.84 | -43.2% | |
| 31 de marzo de 2025 | $-0.81 | $-0.75 | -8.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $215M | $126M | $78M | $69M | $22M | $45M | |
| SG&A Expense | $100M | $41M | $24M | $22M | $12M | $4M | |
| Operating Expenses | $315M | $167M | $102M | $91M | $34M | $52M | |
| Operating Income | $-315M | $-167M | $-102M | $-91M | $-34M | $-52M | |
| Interest Expense | · | · | $4M | $992.0K | $20.0K | $166.0K | |
| Interest Income | $24M | $21M | $8M | $2M | $15.0K | $8.0K | |
| Other Non-op | $16M | $15M | $6M | $2M | $2M | $-1M | |
| Pretax Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $-1.0K | |
| Net Income | $-300M | $-152M | $-96M | $-89M | $-33M | $-53M | |
| EPS (Basic) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| EPS (Diluted) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · | |
| Shares (Basic) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| Shares (Diluted) | 64,233,814 | 55,326,680 | 42,707,072 | 26,570,676 | 13,435,706 | · | |
| EBITDA | $-315M | $-167M | $-106M | $-92M | $-34M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $355M | $93M | $46M | $43M | $80M | $54M | |
| Short-term Investments | $360M | $548M | $115M | $71M | $0 | · | |
| Prepaid Expense | $14M | $10M | $11M | $11M | $3M | $557.0K | |
| Other Current Assets | $3M | $1M | $2M | $719.0K | $480.0K | $392.0K | |
| Current Assets | $729M | $651M | $172M | $126M | $83M | $54M | |
| PP&E (Net) | $1M | $960.0K | $92.0K | $51.0K | $0 | · | |
| Other Non-current Assets | $6M | · | · | · | · | · | |
| Total Assets | $735M | $656M | $176M | $131M | $84M | $55M | |
| Accounts Payable | $22M | $8M | $11M | $12M | $1M | $909.0K | |
| Accrued Liabilities | $32M | $16M | $9M | $11M | $6M | $535.0K | |
| Current Liabilities | $53M | $25M | $22M | $26M | $8M | $2M | |
| Capital Leases | $2M | $2M | $1M | $4M | $0 | · | |
| Other Non-current Liabilities | $2M | · | · | · | · | · | |
| Total Liabilities | $130M | $79M | $74M | $55M | $14M | $4M | |
| Long-term Debt | $75M | $51M | $50M | $25M | $5M | $0 | |
| Common Stock | $71.0K | $64.0K | $44.0K | $28.0K | · | · | |
| Retained Earnings | $-761M | $-461M | $-309M | $-213M | $-124M | $-91M | |
| AOCI | $786.0K | $393.0K | $251.0K | $-224.0K | $0 | · | |
| Stockholders' Equity | $605M | $577M | $102M | $77M | $70M | $-89M | |
| Liabilities + Equity | $735M | $656M | $176M | $131M | $84M | $55M |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $468.0K | $105.0K | $21.0K | $-846.0K | $176.0K | $251.0K | |
| Stock-based Comp | $38M | $21M | $11M | $9M | $3M | $331.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | $0 | $3M | |
| Other Non-cash | $20M | $-3M | $-4M | $13M | $6M | · | |
| Operating Cash Flow | $-241M | $-135M | $-92M | $-68M | $-24M | $-35M | |
| CapEx | $630.0K | $972.0K | $63.0K | $62.0K | $0 | $99.0K | |
| Investing Cash Flow | $194M | $-425M | $-39M | $-71M | $-4M | $-42.0K | |
| Stock Issued | · | · | · | $2M | $0 | · | |
| Stock Repurchased | $0 | $13.0K | $0 | · | · | · | |
| Net Stock Activity | $0 | $-13.0K | · | $2M | $51M | · | |
| Financing Cash Flow | $309M | $607M | $134M | $102M | $54M | $85M | |
| Net Change in Cash | $262M | $47M | $2M | $-36M | $26M | $50M | |
| Taxes Paid | $17.0K | $1.0K | $1.0K | · | · | · | |
| Free Cash Flow | $-242M | $-136M | $-92M | $-68M | · | · | |
| Levered FCF | · | · | $-96M | $-69M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -43.1% | -36.6% | -62.5% | -82.8% | -47.2% | · | |
| ROE | -55.9% | -35.1% | -85.2% | -97.5% | -42.1% | · | |
| ROIC | -52.2% | -29.0% | -100.3% | -118.2% | -49.4% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 | · | |
| Quick Ratio | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 | · | |
| Interest Coverage | · | · | -26.9 | -91.6 | -1720.1 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash Flow / Share | $-3.75 | $-2.43 | $-2.16 | $-2.54 | · | · | |
| EPS (TTM) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-300M | $-152M | $-96M | $-89M | $-33M | · | |
| P/E | -10.9 | -15.4 | -6.8 | -5.8 | -11.0 | · | |
| Earnings Yield | -9.2% | -6.5% | -14.6% | -17.3% | -9.1% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $60M | $86M | $59M | $56M | $58M | $41M | $33M | $40M | $29M | $23M | $16M | $16M | $25M | $27M | $20M | $10M | |
| SG&A Expense | $52M | $39M | $35M | $27M | $22M | $16M | $16M | $9M | $8M | $8M | $6M | $6M | $6M | $7M | $6M | $5M | |
| Operating Expenses | $112M | $125M | $94M | $84M | $80M | $57M | $49M | $50M | $37M | $31M | $22M | $22M | $31M | $34M | $25M | $15M | |
| Operating Income | $-112M | $-125M | $-94M | $-84M | $-80M | $-57M | $-49M | $-50M | $-37M | $-31M | $-22M | $-22M | $-31M | $-34M | $-25M | $-15M | |
| Interest Expense | · | · | · | · | · | · | · | · | $2M | $2M | $943.0K | $914.0K | $874.0K | $599.0K | $147.0K | $128.0K | |
| Interest Income | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $5M | $5M | $4M | $2M | $2M | $2M | $894.0K | $567.0K | $263.0K | |
| Other Non-op | $3M | $4M | $3M | $4M | $4M | $6M | $5M | $3M | $4M | $3M | $2M | $2M | $1M | $1M | $565.0K | $204.0K | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $0 | $0 | |
| Net Income | $-109M | $-121M | $-91M | $-80M | $-77M | $-52M | $-43M | $-47M | $-34M | $-28M | $-20M | $-20M | $-30M | $-32M | $-25M | $-15M | |
| EPS (Basic) | $-1.52 | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| EPS (Diluted) | $-1.52 | $-1.69 | $-1.39 | $-1.26 | $-1.20 | $-0.81 | $-0.72 | $-0.85 | $-0.62 | $-0.56 | $-0.45 | $-0.46 | $-0.80 | $-1.18 | $-0.91 | $-0.55 | |
| Shares (Basic) | 71,838,008 | 71,476,595 | · | 63,847,055 | 63,789,303 | 63,671,558 | · | 54,898,297 | 54,728,552 | 50,971,933 | 44,363,419 | 44,269,772 | 37,667,566 | · | 27,215,874 | 27,078,450 | |
| Shares (Diluted) | 71,838,008 | 71,476,595 | · | 63,847,055 | 63,789,303 | 63,671,558 | · | 54,898,297 | 54,728,552 | 50,971,933 | 44,363,419 | 44,269,772 | 37,667,566 | · | 27,215,874 | 27,078,450 | |
| EBITDA | $-112M | $-125M | · | $-84M | $-80M | $-57M | · | $-50M | $-37M | $-33M | $-22M | $-22M | $-32M | · | $-25M | $-15M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $114M | $355M | $58M | $49M | $55M | $93M | $27M | $25M | $69M | $27M | $34M | $137M | $43M | $30M | $50M | |
| Short-term Investments | $450M | $482M | $360M | $440M | $508M | $535M | $548M | $326M | $359M | $335M | $132M | $147M | $60M | $71M | $84M | $82M | |
| Prepaid Expense | $28M | $19M | $14M | $14M | $15M | $16M | $10M | $11M | $10M | $13M | $12M | $10M | $7M | $11M | $11M | $10M | |
| Other Current Assets | $4M | $2M | $3M | $1M | $2M | $2M | $1M | $1M | $429.0K | $568.0K | $2M | $1M | $883.0K | $719.0K | $792.0K | $776.0K | |
| Current Assets | $527M | $616M | $729M | $511M | $571M | $606M | $651M | $364M | $395M | $416M | $172M | $191M | $204M | $126M | $125M | $142M | |
| PP&E (Net) | $813.0K | $945.0K | $1M | $1M | $1M | $1M | $960.0K | $368.0K | $155.0K | $81.0K | $34.0K | $40.0K | $45.0K | $51.0K | $56.0K | $21.0K | |
| Other Non-current Assets | $5M | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $533M | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | $176M | $195M | $210M | $131M | $131M | $149M | |
| Accounts Payable | $15M | $14M | $22M | $18M | $13M | $9M | $8M | $5M | $5M | $5M | $12M | $13M | $5M | $12M | $7M | $7M | |
| Accrued Liabilities | $34M | $31M | $31M | $23M | $20M | $11M | $16M | $20M | $12M | $7M | $10M | $11M | $16M | $11M | $6M | $8M | |
| Current Liabilities | $48M | $45M | $53M | $42M | $34M | $22M | $25M | $26M | $18M | $15M | $25M | $27M | $24M | $26M | $16M | $17M | |
| Capital Leases | · | · | $2M | $2M | $2M | $2M | $2M | $3M | $455.0K | $919.0K | $2M | $3M | $3M | $4M | $4M | $5M | |
| Other Non-current Liabilities | $2M | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $125M | $122M | $130M | $119M | $110M | $75M | $79M | $80M | $69M | $66M | $52M | $55M | $52M | $55M | $26M | $27M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $74M | $51M | $51M | $50M | $50M | $50M | $25M | $25M | $25M | $25M | $5M | $5M | |
| Common Stock | $72.0K | $72.0K | $71.0K | $64.0K | $64.0K | $64.0K | $64.0K | $55.0K | $55.0K | $54.0K | · | · | · | $28.0K | · | · | |
| Retained Earnings | $-991M | $-882M | $-761M | $-670M | $-589M | $-513M | $-461M | $-418M | $-371M | $-337M | $-283M | $-263M | $-243M | $-213M | $-181M | $-156M | |
| AOCI | $-403.0K | $-156.0K | $786.0K | $881.0K | $527.0K | $654.0K | $393.0K | $1M | $-450.0K | $-173.0K | $-75.0K | $-142.0K | $-4.0K | $-224.0K | $-279.0K | $-152.0K | |
| Stockholders' Equity | $408M | $500M | $605M | $399M | $468M | $535M | $577M | $289M | $328M | $354M | $124M | $141M | $158M | $77M | $106M | $122M | |
| Liabilities + Equity | $533M | $622M | $735M | $518M | $579M | $610M | $656M | $369M | $397M | $419M | $176M | $195M | $210M | $131M | $131M | $149M |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $132.0K | $140.0K | $135.0K | $129.0K | $119.0K | $85.0K | $55.0K | $24.0K | $1M | $11.0K | $1M | $517.0K | $-506.0K | $-597.0K | $-152.0K | $-106.0K | |
| Stock-based Comp | $16M | $13M | $11M | $10M | $9M | $8M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-cash | · | $1M | · | · | · | $-11M | · | · | · | $-8M | · | · | $2M | · | · | · | |
| Operating Cash Flow | $-100M | $-106M | $-70M | $-62M | $-55M | $-54M | $-39M | $-37M | $-25M | $-34M | $-23M | $-18M | $-26M | $-21M | $-18M | $-19M | |
| CapEx | $0 | $23.0K | $102.0K | $133.0K | $208.0K | $187.0K | $645.0K | $238.0K | $89.0K | $0 | $0 | $0 | $0 | $0 | $38.0K | $6.0K | |
| Investing Cash Flow | $33M | $-138M | $81M | $70M | $29M | $15M | $-221M | $38M | $-23M | $-219M | $16M | $-86M | $12M | $13M | $-2M | $-42M | |
| Stock Repurchased | · | · | $0 | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $4M | $286M | $797.0K | $20M | $2M | $326M | $739.0K | $3M | $277M | $297.0K | $432.0K | $108M | $21M | $908.0K | $48.0K | |
| Net Change in Cash | $-65M | $-240M | $297M | $9M | $-6M | $-38M | $65M | $2M | $-44M | $23M | $-6M | $-104M | $94M | $13M | $-20M | $-61M | |
| Free Cash Flow | · | $-107M | · | · | · | $-55M | · | · | · | · | · | · | $-26M | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.7% | -19.7% | · | -18.1% | -15.7% | -10.0% | · | -17.1% | -11.4% | -9.0% | -13.1% | -11.7% | -16.1% | · | -22.2% | -12.0% | |
| ROE | -25.0% | -23.4% | · | -23.3% | -19.2% | -11.6% | · | -22.6% | -14.4% | -11.1% | -17.5% | -15.4% | -20.6% | · | -25.8% | -13.9% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 13.6 | · | 12.2 | 17.0 | 27.7 | · | 13.8 | 21.4 | 28.6 | 7.0 | 7.1 | 8.7 | · | 7.9 | 8.2 | |
| Quick Ratio | 10.3 | 13.2 | · | 11.9 | 16.6 | 26.9 | · | 13.4 | 20.9 | 27.8 | 6.5 | 6.7 | 8.4 | · | 7.2 | 7.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -19.5 | -16.3 | -23.1 | -24.0 | -35.8 | · | -171.7 | -117.6 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-1.49 | · | · | · | $-0.85 | · | · | · | $-0.66 | · | · | $-0.70 | · | · | · | |
| EPS (TTM) | $-5.86 | $-5.54 | · | $-3.99 | $-3.58 | $-3.00 | · | $-2.57 | $-2.17 | $-2.01 | $-2.89 | $-3.35 | $-3.44 | · | $-3.14 | $-2.59 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-402M | $-369M | · | $-252M | $-218M | $-175M | · | $-134M | $-108M | $-94M | $-103M | $-107M | $-102M | · | $-73M | $-56M | |
| P/E | -7.3 | -7.3 | · | -7.3 | -6.6 | -8.0 | · | -17.2 | -16.7 | -21.5 | -4.7 | -4.8 | -2.3 | · | -6.8 | -5.3 | |
| Earnings Yield | -13.7% | -13.8% | · | -13.7% | -15.2% | -12.5% | · | -5.8% | -6.0% | -4.7% | -21.1% | -20.9% | -44.3% | · | -14.7% | -19.0% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-300M | $-152M | $-96M | $-89M | $-33M |
| EPS Diluido | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 13.6 | 25.7 | 7.7 | 4.9 | 10.7 |
| Ratio Rápido | 13.4 | 25.3 | 7.2 | 4.5 | 10.4 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-242M | $-136M | $-92M | $-68M | · |
Propietarios institucionales (13F) 240 declarantes · $3.4B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
240
Valor en tenencia
$3.4B
Nuevas posiciones
34
Posiciones cerradas
35
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 34 (-19 vs trimestre anterior) | 35 (+5 vs trimestre anterior) | 99 (+4 vs trimestre anterior) | 65 (+2 vs trimestre anterior) | +4.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $246 636 382 | 5 747 760 | 7,34% | Acciones |
| Avoro Capital Advisors LLC | $245 612 034 | 5 723 888 | 7,31% | Acciones |
| VANGUARD GROUP INC | $180 805 107 | 3 570 401 | 5,38% | Acciones |
| STATE STREET CORP | $178 024 407 | 4 148 786 | 5,30% | Acciones |
| Deep Track Capital, LP | $171 640 000 | 4 000 000 | 5,11% | Acciones |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $168 052 724 | 3 916 400 | 5,00% | Acciones |
| Kynam Capital Management, LP | $124 012 432 | 2 890 059 | 3,69% | Acciones |
| MORGAN STANLEY | $120 124 806 | 2 799 459 | 3,57% | Acciones |
| Sofinnova Investments, Inc. | $119 889 982 | 2 793 987 | 3,57% | Acciones |
| FMR LLC | $119 035 323 | 2 774 070 | 3,54% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $118 234 772 | 2 755 413 | 3,52% | Acciones |
| Eversept Partners, LP | $94 949 961 | 2 212 770 | 2,82% | Acciones |
| Logos Global Management LP | $94 402 000 | 2 200 000 | 2,81% | Acciones |
| Integral Health Asset Management, LLC | $75 092 500 | 1 750 000 | 2,23% | Acciones |
| Bellevue Group AG | $73 410 771 | 1 710 808 | 2,18% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $72 637 914 | 1 692 442 | 2,16% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $64 007 660 | 1 591 043 | 1,90% | Acciones |
| GOLDMAN SACHS GROUP INC | $59 251 630 | 1 380 835 | 1,76% | Acciones |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $55 585 829 | 1 295 405 | 1,65% | Acciones |
| Pictet Asset Management Holding SA | $53 625 486 | 1 249 414 | 1,60% | Acciones |
| DEUTSCHE BANK AG\ | $47 291 369 | 1 102 106 | 1,41% | Acciones |
| Qube Research & Technologies Ltd | $46 479 211 | 1 083 179 | 1,38% | Acciones |
| Woodline Partners LP | $42 954 498 | 1 001 037 | 1,28% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $37 170 604 | 866 243 | 1,11% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $27 585 680 | 642 873 | 0,82% | Acciones |
| VOYA INVESTMENT MANAGEMENT LLC | $27 572 336 | 642 562 | 0,82% | Acciones |
| GREAT POINT PARTNERS LLC | $25 781 873 | 600 836 | 0,77% | Acciones |
| BANK OF AMERICA CORP /DE/ | $25 321 319 | 590 103 | 0,75% | Acciones |
| NORTHERN TRUST CORP | $24 936 117 | 581 126 | 0,74% | Acciones |
| BRAIDWELL LP | $24 232 307 | 564 724 | 0,72% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $23 386 508 | 545 013 | 0,70% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $22 650 172 | 527 853 | 0,67% | Acciones |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $22 040 459 | 510 787 | 0,66% | Acciones |
| Davern Capital Partners, LP | $21 404 881 | 498 832 | 0,64% | Acciones |
| Candriam S.C.A. | $20 066 803 | 468 099 | 0,60% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $19 987 778 | 465 807 | 0,59% | Acciones |
| Elmind Capital, LP | $18 730 987 | 436 518 | 0,56% | Acciones |
| Rock Springs Capital Management LP | $18 347 629 | 427 584 | 0,55% | Acciones |
| Balyasny Asset Management L.P. | $16 089 147 | 374 951 | 0,48% | Acciones |
| ORBIMED ADVISORS LLC | $15 859 364 | 369 596 | 0,47% | Acciones |
| Ikarian Capital, LLC | $13 302 100 | 310 000 | 0,40% | Acciones |
| ARMISTICE CAPITAL, LLC | $12 873 000 | 300 000 | 0,38% | Acciones |
| Nuveen, LLC | $12 804 773 | 298 410 | 0,38% | Acciones |
| READYSTATE ASSET MANAGEMENT LP | $12 663 342 | 295 114 | 0,38% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $11 994 546 | 279 528 | 0,36% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $11 957 215 | 278 658 | 0,36% | Acciones |
| CITIGROUP INC | $11 446 585 | 266 758 | 0,34% | Acciones |
| UBS Group AG | $10 906 950 | 254 182 | 0,32% | Acciones |
| Affinity Asset Advisors, LLC | $10 727 500 | 250 000 | 0,32% | Acciones |
| Alphabet Inc. | $10 352 638 | 241 264 | 0,31% | Acciones |
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Sofinnova Venture Partners X, L.P. ("SVP X"), Sofinnova Management X, L.P. ("SM X LP"), Sofinnova Management X-A, L.L.C. ("SM X LLC"), Dr. James I. Healy ("Healy"), Dr. Maha Katabi ("Katabi") | 5 de marzo de 2026 | 4,00% | Enmienda | Inversión pasiva | SEC |
| Longitude Capital Partners IV, LLC, Longitude Venture Partners IV, L.P., Longitude Prime Partners, LLC, Longitude Prime Fund, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×5 presentaciones | 4 de noviembre de 2024 | · | Presentación inicial | · | SEC |
| Sofinnova Venture Partners X, L.P. (“SVP X”), Sofinnova Management X, L.P. (“SM X LP”), Sofinnova Management X-A, L.L.C. (“SM X LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) ×5 presentaciones | 26 de marzo de 2024 | · | Presentación inicial | Inversión pasiva | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP ×2 presentaciones | 7 de abril de 2022 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 25 insiders · 12 directivos · 10 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Marshall Fordyce | PRESIDENT AND CEO | 15 de septiembre de 2026 M | 235 244 | 0 | 22 | $-9 730 927 |
| Sean Grant | CHIEF FINANCIAL OFFICER | 23 de febrero de 2026 S | 114 181 | 0 | 1 | $-207 759 |
| David Lee Johnson | Chief Operating Officer | 23 de febrero de 2026 S | 45 727 | 0 | 1 | $-108 266 |
| Joseph R Young | SVP, FINANCE, CHIEF ACCT OFFCR | 11 de septiembre de 2026 M | 80 754 | 0 | 2 | $-566 752 |
| Nancy Lee Boman | Chief Regulatory Officer | 3 de agosto de 2026 A | 44 987 | 0 | 0 | $0 |
| Jane Wright Mitchell | Chief Legal Officer | 23 de marzo de 2026 A | 42 403 | 0 | 0 | $0 |
| Laurence Matthew Skelton | Chief Commercial Officer | 23 de febrero de 2026 S | 64 218 | 0 | 1 | $-66 412 |
| Robert Brenner | Chief Medical Officer | 23 de febrero de 2026 S | 50 947 | 0 | 1 | $-90 299 |
| William D. Turner | Chief Regulatory Officer | 23 de febrero de 2026 S | 45 313 | 0 | 4 | $-1 445 710 |
| Jason S Carter | Chief Legal Officer | 21 de noviembre de 2025 S | 49 136 | 0 | 1 | $-107 496 |
| Celia Lin | Chief Medical Officer | 21 de agosto de 2023 S | 11 010 | 0 | 0 | $0 |
| Joanne Curley | Chief Development Officer | 21 de agosto de 2023 S | 26 962 | 0 | 0 | $0 |
| Kimball Hall | Consejero | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Christy J. Oliger | Consejero | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Andrew Cheng | Consejero | 21 de mayo de 2026 A | 17 488 | 0 | 0 | $0 |
| Scott W Morrison | Consejero | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Michael Morrissey | Consejero | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Beth C Seidenberg | Consejero | 21 de mayo de 2026 A | 131 553 | 0 | 0 | $0 |
| Christopher Hite | Consejero | 5 de marzo de 2026 A | · | 0 | 0 | $0 |
| Dr. Maha Katabi | Consejero | 14 de mayo de 2025 A | 2 793 987 | 0 | 0 | $0 |
| Kurt Von Emster | Consejero | 18 de mayo de 2021 C | 2 960 231 | 0 | 0 | $0 |
| COMMODORE CAPITAL LP | Propietario del 10% | 10 de enero de 2024 S | 4 400 000 | 0 | 0 | $0 |
| Abingworth LLP | Propietario del 10% | 13 de mayo de 2021 A | 2 960 231 | 0 | 0 | $0 |
| James R Meyers | · | 21 de mayo de 2026 A | · | 0 | 0 | $0 |
| Patrick G. Enright | · | 21 de mayo de 2026 A | 5 882 | 1 | 0 | $249 985 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 32 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,63% | 9 072 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,58% | 89 811 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,16% | 1 227 NS | 31 de julio de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 68 530 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,15% | 5 108 SH | 1 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,15% | 447 454 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,14% | 601 982 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 367 755 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,07% | 1 634 337 SH | 11 de septiembre de 2026 | Diario |
| BKSE · BNY Mellon ETF Trust | 0,07% | 1 841 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 14 351 NS | 31 de julio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,07% | 30 600 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 16 721 SH | 11 de septiembre de 2026 | Diario |
| ESML · iShares Trust | 0,05% | 45 356 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 25 265 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,03% | 145 920 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 759 354 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,03% | 128 886 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 20 725 SH | 30 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 20 341 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2 757 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,01% | 5 214 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 5 306 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 92 764 SH | 11 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,00% | 10 449 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 39 169 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 15 089 SH | 10 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 7 498 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 934 442 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 315 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 2 430 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 63 574 SH | 11 de septiembre de 2026 | Diario |
VERA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 20 analistas
COMPRA
Objetivo mediano
$81.50
+167,9%
7 35,0%
Compra fuerte
11 55,0%
Compra
2 10,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
14 analistas · 2026-10-01Objetivo medio $77.50 +154,8%
← Por Debajo de Todos los Objetivos
Precio Actual $30.42
Mín$34.00
Media$77.50
Máx$100.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| VERA | · | -10.9 | · | · | -55.9% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026